Literature DB >> 18450512

Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics.

Erica L Dahl1, Philip J Rosenthal.   

Abstract

Several antibiotics possess antimalarial properties, although the mechanisms by which they kill malaria parasites have been poorly understood. Recent data suggest that the target for multiple antimalarial antibiotics is the apicoplast, a chloroplast-like organelle of uncertain function. Translation inhibitors (such as tetracyclines, clindamycin and macrolides) and gyrase inhibitors (such as ciprofloxacin) cause modest antimalarial effects initially but are much more potent against the progeny of treated parasites. These progeny inherit nonfunctional apicoplasts, suggesting that blocking production of apicoplast proteins causes the 'delayed-death effect'. Interestingly, the antibiotics thiostrepton and rifampin are fast acting and might target additional processes outside the apicoplast.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18450512     DOI: 10.1016/j.pt.2008.03.007

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  54 in total

1.  Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches.

Authors:  Eric H Ekland; Jessica Schneider; David A Fidock
Journal:  FASEB J       Date:  2011-07-11       Impact factor: 5.191

2.  Mitochondrial and plastid genome architecture: Reoccurring themes, but significant differences at the extremes.

Authors:  David Roy Smith; Patrick J Keeling
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-26       Impact factor: 11.205

3.  Toxoplasma gondii nucleus coding apicoplast protein ACP synthesis and trafficking in delayed death.

Authors:  Liang Wu; Jin Shen; Yupei Zhou; Xiao Wang; Lamei Wu; Xugan Jiang; Shengxia Chen
Journal:  Parasitol Res       Date:  2015-01-07       Impact factor: 2.289

Review 4.  Translational control in Plasmodium and toxoplasma parasites.

Authors:  Min Zhang; Bradley R Joyce; William J Sullivan; Victor Nussenzweig
Journal:  Eukaryot Cell       Date:  2012-12-14

5.  The biochemistry and fidelity of synthesis by the apicoplast genome replication DNA polymerase Pfprex from the malaria parasite Plasmodium falciparum.

Authors:  Scott R Kennedy; Cheng-Yao Chen; Michael W Schmitt; Cole N Bower; Lawrence A Loeb
Journal:  J Mol Biol       Date:  2011-05-05       Impact factor: 5.469

6.  Discovery of compounds blocking the proliferation of Toxoplasma gondii and Plasmodium falciparum in a chemical space based on piperidinyl-benzimidazolone analogs.

Authors:  Nadia Saïdani; Cyrille Y Botté; Michael Deligny; Anne-Laure Bonneau; Janette Reader; Ronald Lasselin; Goulven Merer; Alisson Niepceron; Fabien Brossier; Jean-Christophe Cintrat; Bernard Rousseau; Lyn-Marie Birkholtz; Marie-France Cesbron-Delauw; Jean-François Dubremetz; Corinne Mercier; Henri Vial; Roman Lopez; Eric Maréchal
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

7.  Single-stranded DNA binding protein from human malarial parasite Plasmodium falciparum is encoded in the nucleus and targeted to the apicoplast.

Authors:  Dhaneswar Prusty; Ashraf Dar; Rashmi Priya; Atul Sharma; Srikanta Dana; Nirupam Roy Choudhury; N Subba Rao; Suman Kumar Dhar
Journal:  Nucleic Acids Res       Date:  2010-06-22       Impact factor: 16.971

8.  Comparative Genomics and Systems Biology of Malaria Parasites Plasmodium.

Authors:  Hong Cai; Zhan Zhou; Jianying Gu; Yufeng Wang
Journal:  Curr Bioinform       Date:  2012-12-01       Impact factor: 3.543

9.  In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon.

Authors:  Jana Held; Richard Westerman; Peter G Kremsner; Benjamin Mordmüller
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

Review 10.  Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancy.

Authors:  R Matthew Chico; Rudiger Pittrof; Brian Greenwood; Daniel Chandramohan
Journal:  Malar J       Date:  2008-12-16       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.